Similarly, CB1‐ and CB2‐dependent analgesia has been shown in diabetic neuropathy and cancer‐induced bone pain, as well as PIPN (Deng et al., 2012; Gonçalves et al., 2022; Lin et al., 2022; Lozano‐Ondoua et al., 2010, 2013; Toniolo et al., 2022; Xu et al., 2014; Zeng et al., 2024; Zhang et al., 2018). Here, CNR1 is linked to cancer.